| Kaiser Foundation Health Plan Northern California |
| Blenrep (belantamab mafodotin-blmf) |
| Drugs for Cancer : Drugs for Cancer |
- Prior Authorization: Multiple Myeloma:
Documented Diagnosis: Yes
Age Requirement: >= 18
- Multiple Myeloma:
Age Requirement: >= 18
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
Drug Policy Based On: Payer Specific
ECOG Score Requirement in Policy: N/A
ECOG status <=2: No
Diagnosis Types: Adult patients with relapsed or refractory multiple myeloma
|